| Feb 5 2020 |
Travel Ban Update: Administration Adds Six New Countries to List |
Jackson Lewis P.C. |
| Feb 5 2020 |
SECURE Act Accelerates Timing of Required Minimum Distributions to Beneficiaries Under Qualified Plans and IRAs |
Greenberg Traurig, LLP |
| Feb 5 2020 |
CMS Updates Hospital Compare without Updating Evaluation Criteria |
McDermott Will & Schulte LLP |
| Feb 5 2020 |
Best Interest Standard of Care for Advisors #24 |
Faegre Drinker |
| Feb 5 2020 |
Stakeholders Push for the Adoption of CMS and ONC Interoperability Rules |
McDermott Will & Schulte LLP |
| Feb 5 2020 |
SEC Proposes Expanding “Accredited Investor” and “Qualified Institutional Buyer” Definitions |
Mintz |
| Feb 5 2020 |
FDA Approves Drug to Treat Peanut Allergy in Children |
Keller and Heckman LLP |
| Feb 5 2020 |
Coronavirus Edition: What Did I Do Wrong?? Common FMLA Mistakes |
Jackson Lewis P.C. |
| Feb 5 2020 |
Part 25 of “The Restricting Covenant” Series: Disintermediation and Noncompetes |
Faegre Drinker |
| Feb 5 2020 |
Health and Human Services Exchange Program Integrity Final Rule |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 5 2020 |
Agencies’ Antitrust Suit Against Drug Maker Underscores Challenges of Bringing Biosimilars to Market |
MoginRubin |
| Feb 4 2020 |
FCC Follows FTC With Outreach To Gateway Carriers |
Squire Patton Boggs (US) LLP |
| Feb 4 2020 |
FTC Announces 2020 ‘Size of Transaction Thresholds’ |
MoginRubin |
| Feb 4 2020 |
Coronavirus Update for U.S. Employers |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Feb 4 2020 |
Coronavirus and Force Majeure |
Squire Patton Boggs (US) LLP |
| Feb 4 2020 |
2019 IP Law Year In Review – Trademarks |
McDermott Will & Schulte LLP |
| Feb 4 2020 |
Title VII Reminder: Coronavirus No Excuse for National Origin Discrimination |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Feb 4 2020 |
SEC Issues MD&A Disclosure Guidance and Proposes Amendments to Modernize and Enhance MD&A Financial Disclosures |
Greenberg Traurig, LLP |
| Feb 4 2020 |
Letters of Wishes: An Administrative and Moral Headache in Disguise? |
Horwood Marcus & Berk Chartered |
| Feb 4 2020 |
Using Nonqualified Plans to Reduce 401(k)/403(b) Costs |
Carlton Fields |
| Feb 4 2020 |
Cyber Criminals Using Coronavirus Concern to Assist with Intrusions |
Robinson & Cole LLP |
| Feb 4 2020 |
Bridging the Week by Gary DeWaal: January 27 to 31 and February 3, 2020 (More Hedge Exemptions; FCM Liability for Omnibus Client; Cybersecurity) |
Katten |
| Feb 4 2020 |
Will the Coronavirus Make Your Business Sick? |
Much Shelist, P.C. |
| Feb 4 2020 |
3 Key Risk Management Responses to the Coronavirus |
Risk and Insurance Management Society, Inc. (RIMS) |
| Feb 4 2020 |
Trump Administration Adds Six Countries to Travel Ban |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Feb 4 2020 |
How Law Firms Can Prevent Phishing and Malware |
PracticePanther |
| Feb 4 2020 |
New Government Action Aims to Increase Competition among Biological Products: FDA and FTC Step Up Industry Pressure |
Mintz |
| Feb 4 2020 |
Anticompetitive Conduct in Biologics – An Enforcement Priority with FTC and FDA |
McDermott Will & Schulte LLP |
| Feb 4 2020 |
Nanotechnology Entrepreneurship Network Webinar on Insights from the U.S. Patent and Trademark Office Will Be Held February 5 |
Bergeson & Campbell, P.C. |
| Feb 4 2020 |
Episode 7: HIPAA Risk Analysis 2.0: Duty of Care Risk Analysis [PODCAST] |
Foley & Lardner LLP |
| Feb 4 2020 |
The Duty to Account of a Power of Attorney |
Stark & Stark |
| Feb 4 2020 |
Travel Restrictions, New Facts on Coronavirus Should be Continually Monitored by Employers |
Jackson Lewis P.C. |
| Feb 4 2020 |
Many Companies Face Obligations Under the TSCA Fees Rule |
Beveridge & Diamond PC |
| Feb 4 2020 |
OFCCP Director Leen Nominated to Serve as OPM Inspector General |
Proskauer Rose LLP |
| Feb 4 2020 |
Hold Your Water – Navigating the new rule defining “Waters of the United States” |
Foley & Lardner LLP |
